Acute-on-chronic liver failure is a syndrome that affects patients with chronic liver disease; is characterized by intense systemic inflammation, organ failure, and a poor prognosis; and frequently develops in close association with precipitating events. There is no specific treatment for patients with ACLF, and management is based on organ support, management of complications associated with specific etiologies, and liver transplantation.
This report contains market size and forecasts of Acute On Chronic Liver Failure in Global, including the following market information:
Global Acute On Chronic Liver Failure Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Acute On Chronic Liver Failure market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acute On Chronic Liver Failure include Grifols Therapeutics, Promethera Biosciences, RHEACELL, Versantis AG and Martin pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute On Chronic Liver Failure companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute On Chronic Liver Failure Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Acute On Chronic Liver Failure Market Segment Percentages, by Type, 2021 (%)
Surgery
Medication
Others
Global Acute On Chronic Liver Failure Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Acute On Chronic Liver Failure Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Acute On Chronic Liver Failure Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Acute On Chronic Liver Failure Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute On Chronic Liver Failure revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Acute On Chronic Liver Failure revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grifols Therapeutics
Promethera Biosciences
RHEACELL
Versantis AG
Martin pharmaceuticals